<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Diagn Pathol</journal-id>
      <journal-id journal-id-type="iso-abbrev">Diagn Pathol</journal-id>
      <journal-title-group>
        <journal-title>Diagnostic Pathology</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1746-1596</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
        <publisher-loc>London</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">26088594</article-id>
      <article-id pub-id-type="pmc">4474441</article-id>
      <article-id pub-id-type="publisher-id">307</article-id>
      <article-id pub-id-type="doi">10.1186/s13000-015-0307-z</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Focal invasiveness in complete histological analyses of a large acral lentiginous melanoma</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Xavier-J&#xFA;nior</surname>
            <given-names>Jos&#xE9; C&#xE2;ndido Caldeira</given-names>
          </name>
          <address>
            <email>josecandidojr@yahoo.com.br</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Munhoz</surname>
            <given-names>Tania</given-names>
          </name>
          <address>
            <email>tania_mia8@yahoo.com.br</email>
          </address>
          <xref ref-type="aff" rid="Aff2"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Souza</surname>
            <given-names>Vinicius</given-names>
          </name>
          <address>
            <email>vaseunesp@yahoo.com.br</email>
          </address>
          <xref ref-type="aff" rid="Aff2"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>de Campos</surname>
            <given-names>Elo&#xED;sa Bueno Pires</given-names>
          </name>
          <address>
            <email>elopires@fmb.unesp.br</email>
          </address>
          <xref ref-type="aff" rid="Aff2"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Stolf</surname>
            <given-names>Hamilton Ometto</given-names>
          </name>
          <address>
            <email>hstolf@fmb.unesp.br</email>
          </address>
          <xref ref-type="aff" rid="Aff2"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Marques</surname>
            <given-names>Mari&#xE2;ngela Esther Alencar</given-names>
          </name>
          <address>
            <email>mmarques@fmb.unesp.br</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <aff id="Aff1"><label/>Department of Pathology, Botucatu Medical School, Paulista State University (UNESP), Rubi&#xE3;o J&#xFA;nior s/n 18618-970, Botucatu, SP Brazil </aff>
        <aff id="Aff2"><label/>UNESP- Universidade Estadual Paulista Radiology and Dermatology Department, Botucatu, SP Brazil </aff>
      </contrib-group>
      <pub-date pub-type="epub">
        <day>20</day>
        <month>6</month>
        <year>2015</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>20</day>
        <month>6</month>
        <year>2015</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2015</year>
      </pub-date>
      <volume>10</volume>
      <elocation-id>73</elocation-id>
      <history>
        <date date-type="received">
          <day>3</day>
          <month>11</month>
          <year>2014</year>
        </date>
        <date date-type="accepted">
          <day>29</day>
          <month>5</month>
          <year>2015</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; Xavier-J&#xFA;nior et al. 2015</copyright-statement>
        <license license-type="open-access">
          <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0">http://creativecommons.org/licenses/by/4.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
        </license>
      </permissions>
      <abstract id="Abs1">
        <sec>
          <title>Background</title>
          <p>Acral lentiginous melanoma is a melanoma with poor prognosis which is frequently diagnosed at an advanced stage. Since the thickness of tumour is one of the main prognostic factors, this case can exemplify how important complete histological analyses looking for focal invasiveness can be.</p>
        </sec>
        <sec>
          <title>Case report</title>
          <p>A 77&#xA0;year-old woman with a black spot with slow progressive growth on the left plantar region. She sought medical attention due to the expansion onto the dorsal surface of toes. The lesion had irregular borders and had spread to half the plantar surface. Histopathology confirmed the clinical suspicion of acral lentiginous melanoma Clark level IV and 2.6&#xA0;mm Breslow thickness. The surgical specimen was entirely processed for histological evaluation, requiring 53 slides. Tumor dermal invasion was detected in only three out of 53 glass slides as the invasiveness was not identified by clinical, dermatoscopy or macroscopy exams.</p>
        </sec>
        <sec>
          <title>Conclusion</title>
          <p>Sectioning through the entire lesion is considered very important to determinate the appropriate stage of the disease and the correct treatment and patient follow-up.</p>
        </sec>
        <sec>
          <title>Virtual slides</title>
          <p>The virtual slide(s) for this article can be found here: <ext-link ext-link-type="uri" xlink:href="http://www.diagnosticpathology.diagnomx.eu/vs/153617994148349">http://www.diagnosticpathology.diagnomx.eu/vs/1513617994148349</ext-link>.</p>
        </sec>
      </abstract>
      <kwd-group xml:lang="en">
        <title>Keywords</title>
        <kwd>Melanoma</kwd>
        <kwd>Dermatopathology</kwd>
        <kwd>Cancer</kwd>
        <kwd>Acral Lentiginous Melanoma</kwd>
      </kwd-group>
      <custom-meta-group>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>&#xA9; The Author(s) 2015</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <sec id="Sec1" sec-type="introduction">
      <title>Background</title>
      <p>Acral lentiginous melanoma (ALM) is a common type of melanoma which should be considered as a clinicopathologic entity [<xref ref-type="bibr" rid="CR1">1</xref>]. AML is the most frequent type of melanoma in the Asian population and those with darker skin types [<xref ref-type="bibr" rid="CR2">2</xref>]. Nevertheless, among the white population, there is a predominance of ALM in women, with a peak of incidence during the seventh decade and the foot is the most common site of ALM [<xref ref-type="bibr" rid="CR3">3</xref>].</p>
      <p>ALM occurs, as the name implies, on the acral skin surfaces, with plantar and subungual lesions being the most common sites in 60&#xA0;% of patients [<xref ref-type="bibr" rid="CR2">2</xref>]. It usually presents as a pigmented macule or papule with irregular borders and variegated pigmentation on the palmar and plantar regions [<xref ref-type="bibr" rid="CR2">2</xref>]. It has been theorized that chronic trauma may be a predisposing factor [<xref ref-type="bibr" rid="CR2">2</xref>], but the pathogenesis remains unknown [<xref ref-type="bibr" rid="CR3">3</xref>].</p>
      <p>A worse prognosis for ALM is observed than for other subtypes of melanoma. This may be partially explained by the following: patients with ALM are usually older than patients with other subtypes of melanoma; ALM is often diagnosed at a more advanced stage; the anatomic site of disease (acral region) is hidden and it may have an unusual clinical presentation [<xref ref-type="bibr" rid="CR2">2</xref>&#x2013;<xref ref-type="bibr" rid="CR4">4</xref>].</p>
      <p>The hallmark of ALM is characterized by an asymmetric proliferation of continuous single melanocytes at the dermal-epidermal junction, made up of single melanocytes over nests. Development of nests and prominent pagetoid spread would appear later in the evolution of this kind of tumor [<xref ref-type="bibr" rid="CR2">2</xref>]. The American Joint Committee on Cancer (AJCC) melanoma staging from 2009 indicates that for localized disease, the thickness, ulceration and mitotic rate are the strongest prognostic factors when evaluating the primary tumor.</p>
      <p>Since AML is frequently diagnosed at an advanced stage, there is no consensus about grossing procedure and the thickness of tumor is one of the main prognostic factors. It is important to exemplify how important complete histological analyses can be when looking for focal invasiveness.</p>
    </sec>
    <sec id="Sec2">
      <title>Case presentation</title>
      <p>A 77&#xA0;year-old, woman presented with a black spot on the left plantar region which initially developed approximately 10&#xA0;years ago, and had a slow progressive growth. She sought medical attention due to the lesion expanding onto the dorsal surface of toes. The lesion had irregular borders and spread to half plantar surface until the interdigital region (Figs.&#xA0;<xref rid="Fig1" ref-type="fig">1</xref> and <xref rid="Fig2" ref-type="fig">2</xref>). She reported a previous history of ischemic stroke 8&#xA0;years previously, type 2 diabetes mellitus, and hypertension.<fig id="Fig1"><label>Fig. 1</label><caption><p>Large asymmetric dark-brown macule, irregular borders, with several different colors</p></caption><graphic xlink:href="13000_2015_307_Fig1_HTML" id="MO1"/></fig><fig id="Fig2"><label>Fig. 2</label><caption><p>Brown macule progressing through interdigital region and dorsal surface of the fingers</p></caption><graphic xlink:href="13000_2015_307_Fig2_HTML" id="MO2"/></fig></p>
      <p>In dermatoscopy analyses of darker areas, there was total blurring of the architectural pattern of the ridges and furrows, with obliteration of glandular ostia. In the lighter regions, there was a predilection of the pigment in the ridges. There was presence of peripheral rifling suggesting local expansion and growth; this was consistent with the clinical diagnosis of acral lentiginous melanoma. It is important to highlight that dermatoscopic analyses was not able to determinate focus of invasion in this case.</p>
      <p>Surgical excision of the lesion and a sentinel lymph node biopsy was performed with a satisfactory start to the healing progress by second intention</p>
      <p>The pathology specimen consisted of plantar skin measuring 9.5 &#xD7; 9.0 &#xD7; 0.5&#xA0;cm, showing a macular lesion with irregular borders and with color variegation (brown, dark, black, gray) spreading to digit skin.</p>
      <p>Histopathology confirmed the clinical suspicion of acral lentiginous melanoma, with a vertical growth phase of Clark level IV and 2.6&#xA0;mm Breslow thickness. The mitotic index was 3 mitoses per mm<sup>2</sup>. There was no perineural or intravascular invasion but there was a mild inflammatory host response. There were areas of complete regression. There was no ulceration, microscopic satellites, associated nevus, or involvement of adnexal structures. The surgical margin of the hallux and the interdigital space between the third and fourth toes were positive with involvement by &#x201C;in-situ&#x201D; melanoma. (Figs.&#xA0;<xref rid="Fig3" ref-type="fig">3</xref>, <xref rid="Fig4" ref-type="fig">4</xref> and <xref rid="Fig5" ref-type="fig">5</xref>) The other surgical margins were free from melanoma. The inguinal sentinel lymph node biopsy was negative for melanoma metastasis.<fig id="Fig3"><label>Fig. 3</label><caption><p>Acral lentiginous melanoma, &#x201C;in situ&#x201D; pattern. Most cells are arranged in a linear array along the basal layer and a few nests are also present HE</p></caption><graphic xlink:href="13000_2015_307_Fig3_HTML" id="MO3"/></fig><fig id="Fig4"><label>Fig. 4</label><caption><p>Acral lentiginous melanoma, &#x201C;in situ&#x201D; pattern, detail that points toward the lymphocytic infiltrate in the papillary dermis and the irregular shape of the nests HE</p></caption><graphic xlink:href="13000_2015_307_Fig4_HTML" id="MO4"/></fig><fig id="Fig5"><label>Fig. 5</label><caption><p>Acral lentiginous melanoma focal invasiveness showing a large expanding nodule infiltrating the reticular dermis HE</p></caption><graphic xlink:href="13000_2015_307_Fig5_HTML" id="MO5"/></fig></p>
      <p>The surgical specimen was entirely sectioned for histological evaluation, requiring 53 slides. Tumor invasion was focal in only three slides, invading into the reticular dermis. The other slides demonstrated an increased density of large atypical melanocytes, characterized by nuclear pleomorphism and hyperchromasia and showing a cytoplasmic fixation retraction artifact, scattered along the basal layer and in junctional nests. The epidermis was atrophic with areas of pagetoid and the dermis showed prominent solar elastosis. It is necessary to highlight that the invasiveness had not been identified by clinical, dermatoscopy or macroscopy exams.</p>
      <p>After multidisciplinary discussion and consideration of the positive surgical margins, transmetatarsal amputation with reconstruction using a skin graft from the right lower side of the abdomenal region was required. There was in-situ acral lentiginous melanoma in the residual skin, the surgical margins were free from melanoma.</p>
      <p>The melanoma was stage IIA (T3a N0 M0) based on the AJCC staging scale.</p>
      <p>The patient attends quarterly clinical follow-up with no evidence of melanoma recurrence with appreciated healing of surgical excision.</p>
    </sec>
    <sec id="Sec3" sec-type="discussion">
      <title>Discussion</title>
      <p>There is no consensus about how to process melanocytic lesions. The AJCC Cancer Staging Manual does not discuss this topic [<xref ref-type="bibr" rid="CR5">5</xref>]. The Royal College of Pathologists recommended the examination of the whole lesion [<xref ref-type="bibr" rid="CR6">6</xref>]. Only some studies have made a thorough histological examination of the entire lesion after complete surgical excisions [<xref ref-type="bibr" rid="CR7">7</xref>]. The case presented here is an example of a large AML with focal invasiveness which could only be identified by complete histological analyses.</p>
      <p>It was suggested that pathologists should not hesitate to make AML diagnosis when dealing with an atypical proliferation of melanocytes along the dermal-epidermal junction in a flat, irregular shaped, darkely pigmented lesion bigger than 7&#xA0;mm [<xref ref-type="bibr" rid="CR1">1</xref>].</p>
      <p>Tumour thickness (Breslow depth), male gender, and amelanosis are independent clinical prognostic factors for both ALM-specific and disease-free survival [<xref ref-type="bibr" rid="CR3">3</xref>]. High mitotic rate (&gt;6 mitoses/mm<sup>2</sup>) and presence of microsatellites are other important independent indicators of the metastatic potential of ALM and prognosis [<xref ref-type="bibr" rid="CR4">4</xref>]. In this case, the patient attends clinical follow-up and a good prognosis is expected. For this case, it is important to highlight that without a complete histological examination of the surgical specimen, the patient could be sub- staged. In only three of fifty-three slides, the invasive component was identified. The exact place of the invasion could not be seen by clinical, dermatoscopy or grossing evaluation; only in the histological analysis it was identified.</p>
    </sec>
    <sec id="Sec4" sec-type="conclusion">
      <title>Conclusion</title>
      <p>Even large melanocytic skin specimen, such as the presented case, sectioning through the entire lesion is very important to help determine the appropriate stage of the disease and the correct treatment and follow-up of the patient.</p>
    </sec>
    <sec id="Sec5">
      <title>Consent</title>
      <p>Written informed consent was obtained from the patient for publication of this Case Report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this jornal.</p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn>
        <p>
          <bold>Competing interests</bold>
        </p>
        <p>The authors declare that they have no competing interests.</p>
      </fn>
      <fn>
        <p>
          <bold>Authors&#x2019; contributions</bold>
        </p>
        <p>JCCXJ and MEAM are pathologists responsible for the grossing and histological analyses; TM and VS are the clinicians, EBPC and HOS are the surgeons. All the authors contributed to the acquisition of data, revised the paper and gave final approval.</p>
      </fn>
    </fn-group>
    <ref-list id="Bib1">
      <title>References</title>
      <ref id="CR1">
        <label>1.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Piliang</surname>
              <given-names>MP</given-names>
            </name>
          </person-group>
          <article-title>Acral lentiginous melanoma</article-title>
          <source>Clin Lab Med</source>
          <year>2011</year>
          <volume>31</volume>
          <fpage>281</fpage>
          <lpage>8</lpage>
          <pub-id pub-id-type="doi">10.1016/j.cll.2011.03.005</pub-id>
          <pub-id pub-id-type="pmid">21549241</pub-id>
        </element-citation>
      </ref>
      <ref id="CR2">
        <label>2.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Phan</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Touzet</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Dalle</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Ronger-Savl&#xE9;</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Balme</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Thomas</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>Acral lentiginous melanoma: a clincoprognostic study of 126 cases</article-title>
          <source>Br J Dermatol</source>
          <year>2006</year>
          <volume>155</volume>
          <fpage>561</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1365-2133.2006.07368.x</pub-id>
          <pub-id pub-id-type="pmid">16911282</pub-id>
        </element-citation>
      </ref>
      <ref id="CR3">
        <label>3.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Phan</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Touzet</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Dalle</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Ronger-Savl&#xE9;</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Balme</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Thomas</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>Acral lentiginous melanoma: histopathological prognostic features of 121 cases</article-title>
          <source>Br J Dermatol</source>
          <year>2007</year>
          <volume>157</volume>
          <fpage>311</fpage>
          <lpage>8</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1365-2133.2007.08031.x</pub-id>
          <pub-id pub-id-type="pmid">17596173</pub-id>
        </element-citation>
      </ref>
      <ref id="CR4">
        <label>4.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Balch</surname>
              <given-names>CM</given-names>
            </name>
            <name>
              <surname>Gershenwald</surname>
              <given-names>JE</given-names>
            </name>
            <name>
              <surname>Soong</surname>
              <given-names>SJ</given-names>
            </name>
            <name>
              <surname>Thompson</surname>
              <given-names>JF</given-names>
            </name>
            <name>
              <surname>Atkins</surname>
              <given-names>MB</given-names>
            </name>
            <name>
              <surname>Byrd</surname>
              <given-names>DR</given-names>
            </name>
            <name>
              <surname>Buzaid</surname>
              <given-names>AC</given-names>
            </name>
            <name>
              <surname>Cochran</surname>
              <given-names>AJ</given-names>
            </name>
            <name>
              <surname>Coit</surname>
              <given-names>DG</given-names>
            </name>
            <name>
              <surname>Ding</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Eggermont</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Flaherty</surname>
              <given-names>KT</given-names>
            </name>
            <name>
              <surname>Gimotty</surname>
              <given-names>PA</given-names>
            </name>
            <name>
              <surname>Kirkwood</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>McMasters</surname>
              <given-names>KM</given-names>
            </name>
            <name>
              <surname>Mihm</surname>
              <given-names>MC</given-names>
              <suffix>Jr</suffix>
            </name>
            <name>
              <surname>Morton</surname>
              <given-names>DL</given-names>
            </name>
            <name>
              <surname>Ross</surname>
              <given-names>MI</given-names>
            </name>
            <name>
              <surname>Sober</surname>
              <given-names>AJ</given-names>
            </name>
            <name>
              <surname>Sondak</surname>
              <given-names>VK</given-names>
            </name>
          </person-group>
          <article-title>Final version of 2009 AJCC melanoma staging and classification</article-title>
          <source>J Clin Oncol</source>
          <year>2009</year>
          <volume>27</volume>
          <fpage>6199</fpage>
          <lpage>206</lpage>
          <pub-id pub-id-type="doi">10.1200/JCO.2009.23.4799</pub-id>
          <pub-id pub-id-type="pmid">19917835</pub-id>
        </element-citation>
      </ref>
      <ref id="CR5">
        <label>5.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kwon</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>JH</given-names>
            </name>
            <name>
              <surname>Cho</surname>
              <given-names>KH</given-names>
            </name>
          </person-group>
          <article-title>Acral Lentiginous Melanoma In Situ: A Study of Nine Cases</article-title>
          <source>Am J Dermatopathol</source>
          <year>2004</year>
          <volume>26</volume>
          <fpage>285</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="doi">10.1097/00000372-200408000-00004</pub-id>
          <pub-id pub-id-type="pmid">15249858</pub-id>
        </element-citation>
      </ref>
      <ref id="CR6">
        <label>6.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bravo Puccio</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Chian</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Acral junctional nevus versus acral lentiginous melanoma in situ: a differential diagnosis that should be based on clinicopathologic correlation</article-title>
          <source>Arch Pathol Lab Med</source>
          <year>2011</year>
          <volume>135</volume>
          <fpage>847</fpage>
          <lpage>52</lpage>
          <pub-id pub-id-type="pmid">21732773</pub-id>
        </element-citation>
      </ref>
      <ref id="CR7">
        <label>7.</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Slater</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Walsh</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <source>Dataset for the histological reporting of primary cutaneous malignant melanoma and regional lymph nodes. Standards and datasets for reporting cancers</source>
          <year>2012</year>
          <edition>2</edition>
          <publisher-loc>London, England</publisher-loc>
          <publisher-name>The Royal College of Pathologists</publisher-name>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
